Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Streamex Corp(STEX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for STEX
10/01/2026: STEX (1-star) is currently NOT-A-BUY. Pass it for now.
Streamex Corp is a specialized technology and infrastructure company currently transitioning from a legacy cardiac signal processing business to a blockchain-focused Real-World Asset (RWA) tokenization firm. Its primary growth story centers on the success of its GLDY token and the Streamex Exchange platform, which aim to provide institutional-grade digital commodity exposure. While the pivot offers significant growth potential in the digital finance space, the company faces substantial execution risks, high price volatility, and intense competition from larger financial incumbents. The stock is best suited for growth-oriented investors with high risk tolerance who are looking for speculative exposure to tokenization; monitor institutional adoption of its platform as a key performance indicator.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers high-risk, high-reward exposure to the RWA tokenization theme. |
| Momentum investor | Strong fit while signal remains positive | Momentum may build if institutional AUM growth in GLDY accelerates. |
| Value investor | Weak fit | The lack of consistent profitability makes traditional value metrics inapplicable. |
| Dividend investor | Weak fit | The company does not pay a common stock dividend. |
| Low-risk investor | Weak fit | High price volatility and speculative business model are unsuitable for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock's small-cap status and exposure to speculative fintech contribute to rapid price swings. |
| Valuation risk | Medium / high | Difficulty in valuing early-stage RWA platforms leaves the stock prone to sentiment-driven pricing. |
| Competition risk (Digital asset/fintech) | High | Well-funded competitors could marginalize Streamex's exchange and token products. |
| Business quality | Medium | The firm is currently in a transition phase, making business quality highly dependent on future execution. |
| Dividend income | Low / none | There is no dividend income available to shareholders. |
| Execution risk | High | Successfully bridging legacy medical assets with blockchain infrastructure is a complex and unproven operational goal. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 55.86% | Avg. Invested days 12 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/01/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 145.02M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 1.0M shares | Beta 2.01 | 52 Weeks Range 0.57 - 7.19 | Updated Date 10/01/2026 |
52 Weeks Range 0.57 - 7.19 | Updated Date 10/01/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -9.59 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Tokenized Asset Finance | Fees and yields from the Streamex Exchange and GLDY asset management. | Revenue is tied to the growth of digital assets managed on their blockchain platform. |
| Biomedical Technology | Sale and support of PURE EP cardiac diagnostic hardware. | This is the legacy side of the business providing stable, though small, revenue. |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 71.73M | Price to Sales(TTM) 993.28 |
Enterprise Value 71.73M | Price to Sales(TTM) 993.28 | ||
Enterprise Value to Revenue 491.3 | Enterprise Value to EBITDA -2.34 | Shares Outstanding 116.47M | Shares Floating 87.80M |
Shares Outstanding 116.47M | Shares Floating 87.80M | ||
Percent Insiders 21.88 | Percent Institutions 21.04 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Streamex Corp
Exchange NASDAQ | Headquarters Winter Park, FL, United States | ||
IPO Launch date 2014-10-30 | Co-Founder, CEO & Director Mr. Karl Henry McPhie | ||
Sector Financial Services | Industry Capital Markets | Full time employees 6 | Website https://www.streamex.com |
Full time employees 6 | Website https://www.streamex.com | ||
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias. It also develops and operates the Streamex Exchange platform, a blockchain-based platform that facilitates the tokenization and exchange of real-world assets for the tokenized gold market. In addition, the company offers software support, maintenance, and upgrade services. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is headquartered in Winter Park, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.